327178-94-9

327178-94-9 structure
327178-94-9 structure

Name Sodium (2S,8R)-2-amino-8-[(2H31)hexadecanoyloxy]-5-hydroxy-11-oxo(12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,25,25,26,26,26-2H31)-4,6,10-trioxa-5-phosphahexacosan-1-oate 5-oxide
Synonyms Sodium (2S,8R)-2-amino-8-[(H)hexadecanoyloxy]-5-hydroxy-11-oxo(12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,25,25,26,26,26-H)-4,6,10-trioxa-5-phosphahexa ;cosan-1-oate 5-oxide
Hexadecanoic-d acid, (1R)-1-[[[[(2S)-2-amino-2-carboxyethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, sodium salt (1:1)
Description 12-Dipalmitoyl-sn-glycero-3-PS-d62 (sodium salt) is deuterium labeled 12-Dipalmitoyl-sn-glycero-3-PS.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Molecular Formula C38H11D62NNaO10P
Molecular Weight 820.333
Exact Mass 819.876160